Literature DB >> 1320648

Varicella-zoster virus reactivation without rash.

D H Gilden1, A N Dueland, M E Devlin, R Mahalingam, R Cohrs.   

Abstract

Reactivation of varicella-zoster virus (VZV) leads to localized zoster (shingles), a syndrome characterized by pain and a vesicular rash. Rarely, patients experience radicular pain without zosteriform rash, cases that have been regarded as zoster sine herpete (zoster without rash). Virologic evidence for zoster sine herpete is sparse. However, VZV can produce other neurologic and visceral diseases in the absence of rash or radicular pain. The clinical and virologic features of zoster sine herpete and other disorders produced by VZV without rash are reviewed. Evidence is also presented for the detection of VZV DNA in human blood mononuclear cells of elderly individuals in the absence of skin lesions or other VZV-associated neurologic or systemic disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320648     DOI: 10.1093/infdis/166.supplement_1.s30

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Clinical diagnosis of herpes zoster in family practice.

Authors:  Wim Opstelten; Anton M van Loon; Margje Schuller; Albert J M van Wijck; Gerrit A van Essen; Karel G M Moons; Theo J M Verheij
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

Review 2.  Simian varicella in old world monkeys.

Authors:  Wayne L Gray
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

3.  A treatable cause of lymphocytic meningo-encephalitis.

Authors:  K Fox; E P Wright; J K Ramage
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

4.  Multifocal strokes in a 56-year-old man with HIV infection.

Authors:  Ariel Lefkowitz; Wayne L Gold; Leanne K Casaubon; Daniel M Mandell; Jeffrey Craig
Journal:  CMAJ       Date:  2015-05-25       Impact factor: 8.262

5.  Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases.

Authors:  G P Poggio; C Rodriguez; D Cisterna; M C Freire; J Cello
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 6.  Preventing varicella-zoster disease.

Authors:  Sophie Hambleton; Anne A Gershon
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  HERPES ZOSTER IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION.

Authors:  P C Sanchetee; Y D Singh
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 8.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

10.  Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization.

Authors:  A N Dueland; T Ranneberg-Nilsen; M Degré
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.